{"nct_id":"NCT04394624","title":"Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretreated Patients With NSQ NSCLC (CARMEN-LC04)","status":"TERMINATED","status_verified_date":"2025-05","start_date":"2020-08-31","start_date_type":"ACTUAL","primary_completion_date":"2023-03-06","primary_completion_date_type":"ACTUAL","completion_date":"2024-10-24","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SNY"]}